Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (ALGN) is a global leader in digital orthodontic solutions, pioneering innovations like Invisalign clear aligners and iTero intraoral scanners. This page provides official updates on corporate developments, financial performance, and advancements in digital dentistry.
Access real-time press releases, earnings reports, and strategic announcements directly from the company. Investors will find quarterly results and regulatory filings, while industry professionals can track product launches, clinical studies, and partnership agreements.
Our curated collection includes updates on:
• Financial disclosures (earnings, SEC filings)
• Product innovations (new aligner technologies, scanner enhancements)
• Strategic initiatives (global expansions, research collaborations)
• Industry recognition (awards, clinical study results)
Bookmark this page for streamlined access to ALGN's latest developments. Verify investment hypotheses or stay informed about advancements in clear aligner therapy through primary-source updates.
Align Technology (NASDAQ: ALGN) has announced the commercial availability of its new Invisalign® System with mandibular advancement featuring occlusal blocks (MAOB) in the U.S. and Canada. This innovative treatment solution is designed for Class II skeletal and dental correction in growing patients aged 10-16.
The system addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally, where the lower jaw is positioned too far back relative to the upper jaw. Key features include:
- Solid occlusal blocks with laser welding for structural rigidity
- Simultaneous teeth alignment and mandibular advancement
- Enhanced patient comfort through SmartTrack™ material
- Ability to place attachments under blocks for predictable tooth movement
The product is now available to Invisalign-trained doctors in the U.S., Canada, Australia, and New Zealand, with release in EMEA countries and planned expansion to additional markets throughout 2025.
Align Technology (NASDAQ: ALGN) has announced plans to host an in-person Investor Day on May 6, 2025, starting at 10:00 a.m. Eastern Time. The event will also be available via live audio webcast on the company's investor relations website.
The Investor Day will be primarily focused on institutional investors and sell-side analysts due to space. A replay of the webcast will be accessible within 24 hours after the meeting and remain available for approximately one month.
Align Technology is a global medical device company known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company has served over 271,600 doctor customers and treated more than 19.5 million patients with the Invisalign System over the past 28 years. Align's technology targets a potential market of 600 million consumers worldwide.
Align Technology (NASDAQ: ALGN) has announced the commercial launch of the Invisalign System with mandibular advancement featuring occlusal blocks, designed for Class II skeletal and dental correction. This innovative treatment simultaneously advances the mandible while aligning teeth, primarily targeting growing patients aged 10-16.
The new system addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally. Key features include solid occlusal blocks with laser welding for durability, improved engagement, and vertical opening capabilities. The system is made from patented SmartTrack material, combining SmartForce features and SmartStage technology for predictable tooth movement.
The product is now commercially available in Australia and New Zealand, with release in North America and most EMEA countries. Further market expansion is expected throughout 2025.
Align Technology (ALGN) has announced it will release its first quarter 2025 financial results on Wednesday, April 30, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results.
Align Technology is a global medical device company specializing in clear aligners, intraoral scanners, and CAD/CAM software. The company's portfolio includes the Invisalign® System, iTero™ scanners, and exocad™ software. Currently serving over 271,600 doctors worldwide, Align has treated approximately 19.5 million patients with the Invisalign System over 28 years, targeting a 600 million consumer market opportunity globally.
Align Technology (ALGN) has announced that its Invisalign® brand is becoming an Official Partner of Bay FC, a professional soccer franchise in the National Women's Soccer League (NWSL). The partnership includes the creation of 'Legends of Confidence' content series featuring Bay FC players undergoing Invisalign treatment, sharing their smile journeys.
The collaboration will feature an entitlement night at Bay FC's match against Chicago Stars on April 13 at PayPal Park, including fan activities and giveaways. The partnership also focuses on expanding youth sports access across the Bay Area through community events and initiatives. Bay FC strikers Racheal Kundananji and midfielder Tess Boade have already kicked off the campaign on the team's Instagram.
Align Technology (NASDAQ: ALGN) has launched Align X-ray Insights, an AI-powered computer-aided detection software, in the EU and UK. The solution, which automatically analyzes 2D radiographs, will be showcased at the 2025 IDS Dental Show in Cologne.
The software, part of the Align Digital Platform, helps doctors diagnose dental and oral health conditions through AI detection of caries, periapical radiolucencies, and periodontal bone loss. Early user surveys showed 95% of doctors found it helpful in communicating oral health conditions, while 91% reported improved patient trust and treatment acceptance.
The desktop/tablet version will be available from March 25, 2025, with iTero scanner integration planned for release. The software has received regulatory clearance in Europe, UK, Canada, and New Zealand, with pending approvals in other markets including US FDA 510K clearance. A 60-day free trial is being offered as part of the launch.
Align Technology (NASDAQ: ALGN) has announced enhanced restorative capabilities for its next-generation iTero Lumina™ intraoral scanner and new iTero Lumina™ Pro dental imaging system. The upgraded solutions feature comprehensive capabilities for dental practices, including Near Infra-Red Imaging (NIRI) technology in the Pro version.
The systems are powered by iTero Multi-Direct Capture™ technology offering 3x larger field of view and 25mm maximum capture distance, enabling 2x faster scanning compared to previous models. Key features include superior full jaw clinical accuracy, ability to scan within accuracy threshold of photogrammetry for full-arch implant restorations, and up to 5 capabilities in one device.
The iTero Lumina™ scanner is currently available in multiple regions including the US, Canada, EU, and various Asian countries, while the Pro version is available in select markets. Both systems will be rolled out to additional locations throughout 2025, pending regulatory approvals.
Align Technology (ALGN) has announced plans to repurchase $225 million of its common stock through open market repurchases, completing its $1.0 billion stock repurchase program approved in January 2023.
CFO John Morici stated this decision reflects the company's strong balance sheet, cash flow generation, and management's confidence in capitalizing on market opportunities while providing shareholder value. The repurchases will be executed via a Rule 10b5-1 trading plan and are expected to be completed by early May 2025, funded with Align's cash on hand.
As of December 31, 2024, Align had approximately 73.8 million shares outstanding and $1,043.9 million in cash and cash equivalents. The company continues to focus on making its Invisalign® System the standard of care in orthodontics through its doctor-centered model.
Align Technology (NASDAQ: ALGN) announced that its Invisalign Palatal Expander System has received approval from the Turkish Medicines and Medical Device Agency (TMMDA) and is now available in Turkey. The system offers a removable, safe alternative to traditional palatal expanders for skeletal and dental expansion in patients of all ages.
The system consists of customized 3D-printed devices designed using iTero intraoral scans and proprietary orthodontic software. Combined with Invisalign First™ aligners, it provides a complete early intervention treatment solution for Phase 1 treatment, which represents 20% of orthodontic case starts annually.
The expansion devices are created in small increments to gradually expand a patient's narrow maxilla (upper jaw). This innovation enhances Align's digital orthodontics portfolio, offering doctors improved efficiency and patients better treatment experiences in the EMEA region.
Align Technology (ALGN) reported Q4 2024 total revenues of $995.2 million, up 4.0% year-over-year, with full-year 2024 revenues reaching $4.0 billion, up 3.5% from 2023. Q4 Clear Aligner volumes increased 6.1% year-over-year, while Systems and Services revenues grew 14.9%.
The company's Q4 operating margin was 14.5%, with diluted EPS of $1.39 (GAAP) and $2.44 (non-GAAP). Full-year 2024 operating margin was 15.2%, with diluted EPS of $5.62 (GAAP) and $9.33 (non-GAAP). Foreign exchange impacts negatively affected 2024 revenues by approximately $38.5 million.
Notable achievements include reaching 271,600 active Invisalign trained practitioners and treating 19.5 million patients globally. The company repurchased $352.9 million of common stock in 2024 and ended the year with $1,043.9 million in cash and cash equivalents.
